Overall, these date indicate that rs1800686 and rs3765459 polymorphisms are associated with the ER, PR, C-erbB2 and P53 statuses in breast cancer patients, whereas the rs1883832 and rs4810485 polymorphisms may be involved in breast cancer lymph node metastasis. This evidence concerns the gene ESR1 and breast carcinoma.